ZEAL in “GLP-1 Eats Everything”
Zealand Pharma A/S
Its obesity pipeline, including amylin-based petrelintide, offers direct upside from expanding demand for differentiated weight-loss medicines.
ZEAL impact map — “GLP-1 Eats Everything”
How this story travels from the headline to ZEAL’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.
Loading ZEAL impact map…
Price history, marked with story events
Aug 10, 2020 – Aug 10, 2021 · 253 sessions
Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions
Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…
Full story
GLP-1 Eats Everything
Appetite suppression as a macro variable.
BULL side — Its obesity pipeline, including amylin-based petrelintide, offers direct upside from expanding demand for differentiated weight-loss medicines.
Read the full GLP-1 Eats Everything story